Evidence map›Paper›PMID 33707526›Full record

ArticleScientific reports2021

Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.

Andrew Elliott, Michelle Saul, Jia Zeng, John L Marshall, Edward S Kim, Misako Nagasaka, Heinz-Josef Lenz, Lee Schwartzberg, David Spetzler, Jim Abraham and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Andrew ElliottCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
Michelle SaulCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
Jia ZengCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
John L MarshallRuesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Edward S KimLevine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Misako NagasakaDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Heinz-Josef LenzUniversity of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
Lee SchwartzbergMedical Oncology, West Cancer Center, 9745 Wolf River Blvd, Germantown, TN, USA.
David SpetzlerCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
Jim AbrahamCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
Joanne XiuCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
Phillip StaffordCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.
W Michael KornCaris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA. wmkorn@carisls.com.
Caris Life Sciences (United States) · USGeorgetown University · USLevine Cancer Institute · USThe Barbara Ann Karmanos Cancer Institute · USUniversity of California, San Francisco · USUniversity of Southern California · USWest Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with cancer demonstrate particularly poor outcomes from COVID-19. To provide information essential for understanding the biologic underpinnings of this association, we analyzed whole-transcriptome RNA expression data obtained from a large cohort of cancer patients to characterize expression of ACE2, TMPRSS2, and other proteases that are involved in viral attachment to and entry into target cells. We find substantial variability of expression of these factors across tumor types and identify subpopulations expressing ACE2 at very high levels. In some tumor types, especially in gastrointestinal cancers, expression of ACE2 and TMPRSS2 is highly correlated. Furthermore, we found infiltration with T-cell and natural killer (NK) cell infiltration to be particularly pronounced in ACE2-high tumors. These findings suggest that subsets of cancer patients exist with gene expression profiles that may be associated with heightened susceptibility to SARS-CoV-2 infection, in whom malignant tumors function as viral reservoir and possibly promote the frequently detrimental hyper-immune response in patients infected with this virus.

Indexed as

AgedAngiotensin-Converting Enzyme 2Case-Control StudiesCOVID-19Exome SequencingFemaleHumansMaleMiddle AgedNeoplasmsRNASerine EndopeptidasesTumor MicroenvironmentACE2 protein, humanAngiotensin-Converting Enzyme 2RNASerine EndopeptidasesTMPRSS2 protein, human

Identifiers

PMID33707526
PMCPMC7952699
OpenAlexW3134373887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.